Lixte Biotechnology Holdings, Incorporation operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Lixte Biotechnology Holdings, Incorporation with three other
companies in this sector in the United States:
MYOS RENS Technology Inc
sales of $159,000.00
Regen Biopharma Inc
TG Therapeutics Inc
of which 100%
was License Revenue).